Abstract
Microcystin-LR (MC-LR) has been confirmed to cause blood–brain barrier disruption and enter the brain tissue, resulting in non-negligible toxic effects. However, the neurotoxicity of MC-LR is mainly unknown. This study revealed that MC-LR disrupted the function of the ubiquitin–proteasome system in neurons, which inhibited the degradation of α-synuclein (α-syn), leading to its release from neurons for transport into microglia. α-Syn is the main component of Lewy bodies, which has been identified as one of the main pathological features of Parkinson’s disease (PD). In vitro, we observed that α-syn mediated by MC-LR activated HMC3 cells and polarized them towards M1 type. In addition, we confirmed that α-syn was transported into HMC3 cells through TLR4 receptors and activated the NLRP3 inflammasome, which in turn enhanced the maturation and release of IL-18 and IL-1β. In the mouse models of chronic MC-LR exposure, a large number of inflammatory factors (IL-6, IL-1β, and TNF-α) were deposited in brain tissue, and activation of NLRP3 in microglia was also observed in the midbrain. Collectively, MC-LR exposure promoted the pathological spread of α-syn from cell to cell, activated NLRP3 inflammasome in microglia, and generated neuroinflammation, in which the TLR4 receptor played a substantial effect.
Similar content being viewed by others
Data Availability
The datasets used and/or analyzed in this article are available from the corresponding author on reasonable request.
References
Redouane EM, El Amrani ZS, El Khalloufi F, Oufdou K, Oudra B, Lahrouni M, Campos A, Vasconcelos V (2019) Mode of action and fate of microcystins in the complex soil-plant ecosystems. Chemosphere 225:270–281. https://doi.org/10.1016/j.chemosphere.2019.03.008
Lone Y, Koiri RK, Bhide M (2015) An overview of the toxic effect of potential human carcinogen microcystin-LR on testis. Toxicol Rep 2:289–296. https://doi.org/10.1016/j.toxrep.2015.01.008
He Q, Kang L, Sun X, Jia R, Zhang Y, Ma J, Li H, Ai H (2018) Spatiotemporal distribution and potential risk assessment of microcystins in the Yulin River, a tributary of the Three Gorges Reservoir, China. J Hazard Mater 347:184–195. https://doi.org/10.1016/j.jhazmat.2018.01.001
Zheng C, Zeng H, Lin H, Wang J, Feng X, Qiu Z, Chen JA, Luo J, Luo Y, Huang Y, Wang L, Liu W, Tan Y, Xu A, Yao Y, Shu W (2017) Serum microcystin levels positively linked with risk of hepatocellular carcinoma: a case-control study in southwest China. Hepatology 66(5):1519–1528. https://doi.org/10.1002/hep.29310
Pan C, Zhang L, Meng X, Qin H, Xiang Z, Gong W, Luo W, Li D, Han X (2021) Chronic exposure to microcystin-LR increases the risk of prostate cancer and induces malignant transformation of human prostate epithelial cells. Chemosphere 263:128295. https://doi.org/10.1016/j.chemosphere.2020.128295
Xu D, Yu W, Ma Y, Luo Y, Xu G, Xiang Z, Chen Y, Han X (2021) Association between semen microcystin levels and reproductive quality: a cross-sectional study in Jiangsu and Anhui provinces. China Environ Health Perspect 129(12):127702. https://doi.org/10.1289/EHP9736
Pouria S, de Andrade A, Barbosa J, Cavalcanti RL, Barreto VT, Ward CJ, Preiser W, Poon GK, Neild GH, Codd GA (1998) Fatal microcystin intoxication in haemodialysis unit in Caruaru. Brazil Lancet 352(9121):21–26. https://doi.org/10.1016/s0140-6736(97)12285-1
Li XB, Zhang X, Ju J, Li Y, Yin L, Pu Y (2014) Alterations in neurobehaviors and inflammation in hippocampus of rats induced by oral administration of microcystin-LR. Environ Sci Pollut Res Int 21(21):12419–12425. https://doi.org/10.1007/s11356-014-3151-x
Wang J, Chen Y, Zhang C, Xiang Z, Ding J, Han X (2019) Learning and memory deficits and Alzheimer’s disease-like changes in mice after chronic exposure to microcystin-LR. J Hazard Mater 373:504–518. https://doi.org/10.1016/j.jhazmat.2019.03.106
Wang J, Zhang C, Zhu J, Ding J, Chen Y, Han X (2019) Blood-brain barrier disruption and inflammation reaction in mice after chronic exposure to microcystin-LR. Sci Total Environ 689:662–678. https://doi.org/10.1016/j.scitotenv.2019.06.387
Zhang C, Wang J, Zhu J, Chen Y, Han X (2020) Microcystin-leucine-arginine induced neurotoxicity by initiating mitochondrial fission in hippocampal neurons. Sci Total Environ 703:134702. https://doi.org/10.1016/j.scitotenv.2019.134702
Wang X, Xu L, Li X, Chen J, Zhou W, Sun J, Wang Y (2018) The differential effects of microcystin-LR on mitochondrial DNA in the hippocampus and cerebral cortex. Environ Pollut 240:68–76. https://doi.org/10.1016/j.envpol.2018.04.103
Ju J, Ruan Q, Li X, Liu R, Li Y, Pu Y, Yin L, Wang D (2013) Neurotoxicological evaluation of microcystin-LR exposure at environmental relevant concentrations on nematode Caenorhabditis elegans. Environ Sci Pollut Res Int 20(3):1823–1830. https://doi.org/10.1007/s11356-012-1151-2
Yan M, Jin H, Pan C, Hang H, Li D, Han X (2022) Movement disorder and neurotoxicity induced by chronic exposure to microcystin-LR in mice. Mol Neurobiol. https://doi.org/10.1007/s12035-022-02919-y
Petrucci S, Consoli F, Valente EM (2014) Parkinson disease genetics: a “continuum” from Mendelian to multifactorial inheritance. Curr Mol Med 14(8):1079–1088. https://doi.org/10.2174/1566524014666141010155509
Panicker N, Sarkar S, Harischandra DS, Neal M, Kam TI, Jin H, Saminathan H, Langley M, Charli A, Samidurai M, Rokad D, Ghaisas S, Pletnikova O, Dawson VL, Dawson TM, Anantharam V, Kanthasamy AG, Kanthasamy A (2019) Fyn kinase regulates misfolded alpha-synuclein uptake and NLRP3 inflammasome activation in microglia. J Exp Med 216(6):1411–1430. https://doi.org/10.1084/jem.20182191
Proulx J, Borgmann K, Park IW (2021) Role of virally-encoded deubiquitinating enzymes in regulation of the virus life cycle. Int J Mol Sci 22 (9). https://doi.org/10.3390/ijms22094438
Hedhli N, Depre C (2010) Proteasome inhibitors and cardiac cell growth. Cardiovasc Res 85(2):321–329. https://doi.org/10.1093/cvr/cvp226
Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. https://doi.org/10.1038/nrdp.2017.13
Luk KC, Kehm V, Carroll J, Zhang B, O’Brien P, Trojanowski JQ, Lee VM (2012) Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338(6109):949–953. https://doi.org/10.1126/science.1227157
More SV, Choi DK (2015) Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection. Mol Neurodegener 10:17. https://doi.org/10.1186/s13024-015-0012-0
Ghadery C, Koshimori Y, Coakeley S, Harris M, Rusjan P, Kim J, Houle S, Strafella AP (2017) Microglial activation in Parkinson’s disease using [(18)F]-FEPPA. J Neuroinflammation 14(1):8. https://doi.org/10.1186/s12974-016-0778-1
Beach TG, Sue LI, Walker DG, Lue LF, Connor DJ, Caviness JN, Sabbagh MN, Adler CH (2007) Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits. Acta Neuropathol 114(4):419–424. https://doi.org/10.1007/s00401-007-0250-5
Song DD, Shults CW, Sisk A, Rockenstein E, Masliah E (2004) Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol 186(2):158–172. https://doi.org/10.1016/S0014-4886(03)00342-X
Ancolio K, Alves da Costa C, Ueda K, Checler F (2000) Alpha-synuclein and the Parkinson’s disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells. Neurosci Lett 285(2):79–82. https://doi.org/10.1016/s0304-3940(00)01049-1
Su X, Maguire-Zeiss KA, Giuliano R, Prifti L, Venkatesh K, Federoff HJ (2008) Synuclein activates microglia in a model of Parkinson’s disease. Neurobiol Aging 29(11):1690–1701. https://doi.org/10.1016/j.neurobiolaging.2007.04.006
Lema Tome CM, Tyson T, Rey NL, Grathwohl S, Britschgi M, Brundin P (2013) Inflammation and alpha-synuclein’s prion-like behavior in Parkinson’s disease–is there a link? Mol Neurobiol 47(2):561–574. https://doi.org/10.1007/s12035-012-8267-8
Freeman L, Guo H, David CN, Brickey WJ, Jha S, Ting JP (2017) NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes. J Exp Med 214(5):1351–1370. https://doi.org/10.1084/jem.20150237
Ramesh G, MacLean AG, Philipp MT (2013) Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm 2013:480739. https://doi.org/10.1155/2013/480739
Gordon R, Albornoz EA, Christie DC, Langley MR, Kumar V, Mantovani S, Robertson AAB, Butler MS, Rowe DB, O’Neill LA, Kanthasamy AG, Schroder K, Cooper MA, Woodruff TM (2018) Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med 10 (465). https://doi.org/10.1126/scitranslmed.aah4066
Yan M, Gu S, Pan C, Chen Y, Han X (2021) MC-LR-induced interaction between M2 macrophage and biliary epithelial cell promotes biliary epithelial cell proliferation and migration through regulating STAT3. Cell Biol Toxicol 37(6):935–949. https://doi.org/10.1007/s10565-020-09575-9
Cho MH, Cho K, Kang HJ, Jeon EY, Kim HS, Kwon HJ, Kim HM, Kim DH, Yoon SY (2014) Autophagy in microglia degrades extracellular beta-amyloid fibrils and regulates the NLRP3 inflammasome. Autophagy 10(10):1761–1775. https://doi.org/10.4161/auto.29647
Haque ME, Akther M, Jakaria M, Kim IS, Azam S, Choi DK (2020) Targeting the microglial NLRP3 inflammasome and its role in Parkinson’s disease. Mov Disord 35(1):20–33. https://doi.org/10.1002/mds.27874
Xiao Y, Jin J, Chang M, Chang JH, Hu H, Zhou X, Brittain GC, Stansberg C, Torkildsen O, Wang X, Brink R, Cheng X, Sun SC (2013) Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation. Nat Med 19(5):595–602. https://doi.org/10.1038/nm.3111
Mori A, Hatano T, Inoshita T, Shiba-Fukushima K, Koinuma T, Meng H, Kubo SI, Spratt S, Cui C, Yamashita C, Miki Y, Yamamoto K, Hirabayashi T, Murakami M, Takahashi Y, Shindou H, Nonaka T, Hasegawa M, Okuzumi A, Imai Y, Hattori N (2019) Parkinson’s disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and alpha-synuclein stability through membrane remodeling. Proc Natl Acad Sci U S A 116(41):20689–20699. https://doi.org/10.1073/pnas.1902958116
Mao K, Chen J, Yu H, Li H, Ren Y, Wu X, Wen Y, Zou F, Li W (2020) Poly (ADP-ribose) polymerase 1 inhibition prevents neurodegeneration and promotes alpha-synuclein degradation via transcription factor EB-dependent autophagy in mutant alpha-synucleinA53T model of Parkinson’s disease. Aging Cell 19(6):e13163. https://doi.org/10.1111/acel.13163
Myeku N, Figueiredo-Pereira ME (2011) Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome 1/p62. J Biol Chem 286(25):22426–22440. https://doi.org/10.1074/jbc.M110.149252
Ingelsson M (2016) Alpha-synuclein oligomers-neurotoxic molecules in Parkinson’s disease and other Lewy body disorders. Front Neurosci 10:408. https://doi.org/10.3389/fnins.2016.00408
Mondal A, Saha P, Bose D, Chatterjee S, Seth RK, Xiao S, Porter DE, Brooks BW, Scott GI, Nagarkatti M, Nagarkatti P, Chatterjee S (2021) Environmental microcystin exposure in underlying NAFLD-induced exacerbation of neuroinflammation, blood-brain barrier dysfunction, and neurodegeneration are NLRP3 and S100B dependent. Toxicology 461:152901. https://doi.org/10.1016/j.tox.2021.152901
Tang Y, Le W (2016) Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol Neurobiol 53(2):1181–1194. https://doi.org/10.1007/s12035-014-9070-5
La Vitola P, Balducci C, Cerovic M, Santamaria G, Brandi E, Grandi F, Caldinelli L, Colombo L, Morgese MG, Trabace L, Pollegioni L, Albani D, Forloni G (2018) Alpha-synuclein oligomers impair memory through glial cell activation and via Toll-like receptor 2. Brain Behav Immun 69:591–602. https://doi.org/10.1016/j.bbi.2018.02.012
Tu HY, Yuan BS, Hou XO, Zhang XJ, Pei CS, Ma YT, Yang YP, Fan Y, Qin ZH, Liu CF, Hu LF (2021) alpha-synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson’s disease. Aging Cell 20(12):e13522. https://doi.org/10.1111/acel.13522
Li Y, Liang W, Guo C, Chen X, Huang Y, Wang H, Song L, Zhang D, Zhan W, Lin Z, Tan H, Bei W, Guo J (2020) Renshen Shouwu extract enhances neurogenesis and angiogenesis via inhibition of TLR4/NF-kappaB/NLRP3 signaling pathway following ischemic stroke in rats. J Ethnopharmacol 253:112616. https://doi.org/10.1016/j.jep.2020.112616
Funding
This work was supported by the National Natural Science Foundation of China (31870492, 31901182, 31670519, and 31971517), the Natural Science Foundation of Jiangsu Province of China (BK20190316), and Fundamental Research Funds for the Central Universities (0214–14380438 and 0214–14380471).
Author information
Authors and Affiliations
Contributions
Minghao Yan—writing of the first draft, manuscript preparation. Haibo Jin—writing of the first draft, review, and critique. Chun Pan—writing of the first draft, review, and critique. Xiaodong Han—review and critique.
Corresponding author
Ethics declarations
Ethics Approval and Consent to Participate
All animal procedures were performed humanely and approved by the Nanjing University Animal Care and Use Committee under animal protocol number SYXK (Su) 2009–0017.
Consent for Publication
All authors have agreed to publish this manuscript.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yan, M., Jin, H., Pan, C. et al. Chronic Microcystin-LR-Induced α-Synuclein Promotes Neuroinflammation Through Activation of the NLRP3 Inflammasome in Microglia. Mol Neurobiol 60, 884–900 (2023). https://doi.org/10.1007/s12035-022-03134-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-022-03134-5